Researchers Engineer Bacterial Extracellular Vesicles as Customizable ‘Nanoweapons’ to Combat Global Antimicrobial Resistance

Researchers transform natural bacterial vesicles into engineered "nanoweapons" to deliver targeted drugs and kill drug-resistant pathogens.

By: AXL Media

Published: Apr 27, 2026, 7:09 AM EDT

Source: Information for this report was sourced from Science and Technology Review Publishing House

Researchers Engineer Bacterial Extracellular Vesicles as Customizable ‘Nanoweapons’ to Combat Global Antimicrobial Resistance - article image
Researchers Engineer Bacterial Extracellular Vesicles as Customizable ‘Nanoweapons’ to Combat Global Antimicrobial Resistance - article image

The Biological Potential of Bacterial Extracellular Vesicles

As the global medical community grapples with the escalating threat of antimicrobial resistance, researchers are turning toward the natural defense mechanisms of bacteria themselves. Bacterial extracellular vesicles (BEVs) are nanosized, lipid-bound particles naturally secreted by both gram-negative and gram-positive bacteria. These vesicles function as biological "messengers," carrying a complex cargo of proteins, nucleic acids, and metabolites that influence competition between bacterial species. Because they are naturally designed to penetrate tissues and interact with cellular membranes, BEVs offer a highly efficient, biological delivery system that far surpasses the limited targeting capabilities of traditional small-molecule antibiotics.

Intrinsic Antibacterial and Antiadhesion Capabilities

Natural BEVs possess an inherent ability to kill competing pathogens, a trait that researchers are now seeking to harness for clinical use. These vesicles can deliver specific enzymes, such as autolysins and hydrolases, which physically degrade the cell walls of harmful bacteria. Furthermore, BEVs can inhibit the formation of biofilms—protective layers that make bacteria up to 1,000 times more resistant to antibiotics. Beyond direct killing, these vesicles can act as antiadhesion agents, blocking pathogens from attaching to host tissues in the first place. This multi-pronged natural strategy allows BEVs to neutralize infections at their earliest stages without the broad-spectrum destruction often caused by conventional drugs.

Engineering Nanoweapons Through Genetic Modification

To move beyond the limitations of natural vesicles, the research team, led by Professor Honggang Hu and Dr. Yejiao Shi, utilized genetic, chemical, and physical engineering to create "customizable nanoweapons." Genetic engineering allows scientists to modify the parent bacteria to produce BEVs that have significantly reduced toxicity for human patients while maintaining a high yield. These modified vesicles can be "programmed" to present specific antigens, making them exceptionally effective as vaccine platforms. By altering the genetic blueprint of the producer cells, researchers can ensure that each vesicle is optimized for a specific therapeutic task, whether it be stimulating an immune response or delivering a lethal dose o...

Categories

Topics

Related Coverage